ENTITY

Probiodrug AG (PBD NA)

Analysis

Health Care • Germany

Vivoryon Therapeutics N.V. operates as a biotechnology company. The Company offers medicines that targets post-translational modifying enzymes. Vivoryon Therapeutics focuses on Alzheimer's disease and oncology. Vivoryon Therapeutics serves patients worldwide.

Refresh

No events found

We’ll display events we find for Probiodrug AG here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00